Tobii Dynavox AB (publ)
Tobii Dynavox AB (publ)
Your view on TDVXF
Overview
What the company does, where it operates, and who runs it.
About Tobii Dynavox AB (publ)
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Fredrik Ruben
- Headquarters
- KarlsrovAegen 2D, Stockholm, SE
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Fredrik Ruben
- Headquarters
- KarlsrovAegen 2D, Stockholm, SE
Tobii Dynavox AB (Publ) develops and sells assistive technology products for communication in Sweden and internationally. The company provides technology and solutions for augmentative and alternative communication for people with disabilities.
It also offers speech generating devices and eye trackers; software and apps for communication, computer access, special education, and analysis; accessories, including keyguards, chargers, mounts, and cases; games; and books. The company was founded in 1983 and is headquartered in Danderyd, Sweden.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Tobii Dynavox AB (publ), and the rating behind it. TDVXF last traded at $9.30, 35.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Tobii Dynavox AB (publ). Starting points for Tobii Dynavox AB (publ): P/E 35.6, EPS $2.14, beta 1.04 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Tobii Dynavox AB (publ). Tobii Dynavox AB (publ) does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Tobii Dynavox AB (publ). Trailing twelve-month EPS for Tobii Dynavox AB (publ) stands at $2.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Tobii Dynavox AB (publ). Tobii Dynavox AB (publ) has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Tobii Dynavox AB (publ) valued side by side against its closest peers. Tobii Dynavox AB (publ) is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Tobii Dynavox AB (publ), and how their positions are changing. At a $981.6M market value, institutional positions materially move Tobii Dynavox AB (publ)'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Tobii Dynavox AB (publ) executives and directors. Shares of Tobii Dynavox AB (publ) have traded between $5.00 and $13.55 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Tobii Dynavox AB (publ). Tobii Dynavox AB (publ) is a $981.6M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Tobii Dynavox AB (publ). Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Tobii Dynavox AB (publ). Coverage tracks Tobii Dynavox AB (publ) within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.